ASML vs PTGX · P/E 57, $665.37B cap vs rev $269.8M
ASML Holding NV ADR (ASML) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the ASML and PTGX stock pages for the full models.
Not investment advice.